MarketCap
Immuron Limited IMRN
€ 0.86
-0.01%
Facebook
X
Telegram
Immuron Limited P/B | IMRN
P/B Jährlich Immuron Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 28.6 | 17.9 | 11.6 | 23.5 | - | - | 44.5 | 86.4 | 133 | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in AUD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 133 | 11.6 | 49.3 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Vir Biotechnology
VIR
|
1.33 | $ 11.02 | 4.27 % | $ 1.53 B |  USA |
 |
Viking Therapeutics
VKTX
|
4.98 | $ 24.23 | -0.72 % | $ 2.73 B | USA |
 |
CymaBay Therapeutics
CBAY
|
11.7 | - | - | $ 3.45 B | USA |
 |
Freeline Therapeutics Holdings plc
FRLN
|
4.98 | - | - | $ 384 M |  Britain |
 |
Cabaletta Bio
CABA
|
2.53 | $ 1.34 | -9.18 % | $ 135 M | USA |
 |
CytomX Therapeutics
CTMX
|
9.4 | $ 2.23 | -4.09 % | $ 308 M | USA |
 |
Vanda Pharmaceuticals
VNDA
|
1.09 | $ 3.95 | -1.62 % | $ 233 M | USA |
 |
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | USA |
 |
Timber Pharmaceuticals
TMBR
|
0.846 | - | - | $ 717 K | USA |
 |
Verrica Pharmaceuticals
VRCA
|
2.7 | $ 3.4 | -3.68 % | $ 36.2 M | USA |
 |
Viridian Therapeutics
VRDN
|
4.14 | $ 23.31 | 4.2 % | $ 2.37 B | USA |
 |
G1 Therapeutics
GTHX
|
4.9 | - | - | $ 370 M | USA |
 |
Verastem
VSTM
|
7.06 | $ 9.9 | -1.34 % | $ 686 M | USA |
 |
VistaGen Therapeutics
VTGN
|
0.611 | $ 0.17 | -3.9 % | $ 6.47 M | USA |
 |
Voyager Therapeutics
VYGR
|
1.23 | $ 1.76 | 0.86 % | $ 103 M | USA |
 |
Amryt Pharma plc
AMYT
|
7.14 | - | - | $ 621 M | Britain |
 |
Kinnate Biopharma
KNTE
|
0.778 | - | - | $ 123 M | USA |
|
Cerevel Therapeutics Holdings
CERE
|
9.92 | - | - | $ 7.29 B | USA |
 |
NexImmune
NEXI
|
1.04 | - | 70.13 % | $ 4.12 M | USA |
 |
Wave Life Sciences Ltd.
WVE
|
4.94 | $ 3.23 | -0.16 % | $ 545 M |  Singapore |
 |
Theravance Biopharma
TBPH
|
1.53 | $ 17.03 | 0.03 % | $ 857 M |  Cayman-islands |
 |
Xenetic Biosciences
XBIO
|
0.591 | $ 1.72 | 3.78 % | $ 2.93 M | USA |
|
XBiotech
XBIT
|
0.502 | $ 1.82 | -5.7 % | $ 55.5 M | USA |
 |
Xenon Pharmaceuticals
XENE
|
4.1 | $ 35.76 | 1.19 % | $ 2.83 B |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
70.7 | $ 10.21 | 0.05 % | $ 1.64 B | USA |
 |
X4 Pharmaceuticals
XFOR
|
0.96 | $ 3.26 | 0.46 % | $ 138 M | USA |
 |
IMV
IMV
|
-1.04 | - | - | $ 13.1 M | Canada |
 |
22nd Century Group
XXII
|
0.0293 | $ 0.09 | -54.43 % | $ 16.6 K | USA |
 |
Karuna Therapeutics
KRTX
|
9.4 | - | - | $ 12.2 B | USA |
 |
Chimerix
CMRX
|
0.537 | - | - | $ 756 M | USA |
 |
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | USA |
 |
LogicBio Therapeutics
LOGC
|
2.43 | - | - | $ 229 M | USA |
 |
Zai Lab Limited
ZLAB
|
30.2 | $ 24.36 | 1.35 % | $ 26.7 B |  China |
|
89bio
ETNB
|
2.44 | - | - | $ 1.55 B | USA |
 |
Zentalis Pharmaceuticals
ZNTL
|
0.888 | $ 2.06 | -6.79 % | $ 148 M | USA |
 |
Zymeworks
ZYME
|
3.39 | $ 28.38 | 0.57 % | $ 1.46 B | Canada |
 |
Fusion Pharmaceuticals
FUSN
|
6.22 | - | - | $ 1.41 B | Canada |
 |
Gritstone Oncology
GRTS
|
5.33 | - | 0.42 % | $ 213 M | USA |
 |
Harpoon Therapeutics
HARP
|
3.99 | - | - | $ 763 M | USA |
 |
HOOKIPA Pharma
HOOK
|
0.0747 | - | -6.92 % | $ 79.4 M | USA |
 |
Guardion Health Sciences
GHSI
|
0.539 | - | -0.31 % | $ 3.64 M | USA |
 |
Opiant Pharmaceuticals
OPNT
|
2.49 | - | - | $ 109 M | USA |
 |
Akouos
AKUS
|
0.786 | - | 0.23 % | $ 488 M | USA |
 |
Otonomy
OTIC
|
2.32 | - | -1.96 % | $ 4.68 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | USA |
 |
Seagen
SGEN
|
7.16 | - | - | $ 42.2 B | USA |
 |
Baudax Bio
BXRX
|
-0.0321 | - | 0.59 % | $ 63 K | USA |
 |
ChemoCentryx
CCXI
|
0.00656 | - | - | $ 3.74 B | USA |
 |
Avid Bioservices
CDMO
|
6.95 | - | - | $ 789 M | USA |
 |
Zosano Pharma Corporation
ZSAN
|
1.6 | - | 7.23 % | $ 2.72 M | USA |